This inventor holds 3 USPTO granted patents. Top assignee: Pharmabcine Inc.. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2025
Certainly! Here is the article about the inventor Do-yun Kim:
Title: Innovator Spotlight: Do-yun Kim Revolutionizing Treatment Through Cutting-Edge Antibodies
Introduction:
In the bustling city of Daejeon, South Korea, inventor Do-yun Kim stands as a beacon of innovation in the field of biochemistry and biotechnology. With a passion for combating autoimmune diseases and cancer, Kim has made significant strides in the realm of antibody research, holding a remarkable two patents to his name.
Latest Patents:
Do-yun Kim's latest patents showcase his groundbreaking work in the development of life-saving antibodies. The first patent, titled "Anti-VISTA antibody and use thereof," focuses on an antibody designed to target V-domain Ig suppressor of T cell activation (VISTA), offering a potential solution for autoimmune diseases. His second patent, "EGFRvIII antibody and composition comprising the same," explores an antibody tailored to combat the epidermal growth factor receptor variant III (EGFRvIII), presenting a promising avenue for cancer treatment.
Career Highlights:
Kim is a valued member of Pharmabcine Inc., a leading biopharmaceutical company at the forefront of innovative healthcare solutions. His dedication and expertise have propelled the company's research efforts, leading to groundbreaking discoveries in the realm of antibody therapeutics.
Collaborations:
In his professional journey, Do-yun Kim has had the privilege of collaborating with esteemed colleagues such as Youngae Lee and Sang Soon Byun. Together, they have synergized their expertise to further enhance the field of biotechnology and pave the way for novel treatment modalities.
Conclusion:
Inventor Do-yun Kim's unwavering commitment to advancing healthcare through innovative antibody research is truly commendable. His patents stand as a testament to his dedication to improving the lives of patients worldwide, and his collaborative spirit underscores the importance of teamwork in pushing the boundaries of biopharmaceutical innovation. With Kim at the helm of groundbreaking discoveries, the future of healthcare looks brighter than ever.
If you need more information or have any specific queries, feel free to ask!
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile